Artiva Biotherapeutics Inc (ARTV) Stock Price

10.89 ▼ -1.63 (-13.02%)
Open: 12.05 Vol: 5.29M Day's range: 10.20 - 12.6799 May 08, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ARTV Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 11.23▼ 11.45▼ 11.60▼ 11.54▼ 10.27▲
MA10 11.41▼ 11.70▼ 11.93▼ 10.73▲ 8.04▲
MA20 11.52▼ 11.94▼ 12.10▼ 10.75▲ 6.26▲
MA50 11.73▼ 11.77▼ 11.20▼ 7.91▲ 4.33▲
MA100 11.88▼ 10.87▲ 11.13▼ 6.19▲ N/A    
MA200 11.76▼ 11.26▼ 9.40▲ 4.72▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.063▼ -0.128▼ -0.186▼ -0.056▼ 0.636▲
RSI 23.984▼ 36.251▼ 36.669▼ 55.168▲ 68.551▲
STOCH 7.628▼ 29.304     60.164     66.499     71.415    
WILL %R -100.000▼ -72.279     -72.279     -52.410     -33.364    
CCI -206.044▼ -149.801▼ -200.932▼ 22.698     126.374▲
Latest Filters Detected On ARTV
▼ MACD $ARTV MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $ARTV Price Crossed Below MA(7) Set Alert
▼ GAP $ARTV Open Gap Down %3 Set Alert
▼ GAP $ARTV Open Gap Down %2 Set Alert
Artiva Biotherapeutics Inc News
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
Friday, May 08, 2026 04:48 AM
Initial AlloNK® (AB-101) clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in the company-sponsored Phase 2a basket ...
Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid ...
Friday, May 08, 2026 04:25 AM
Initial clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in the company-sponsored Phase 2a basket trial, with no ...
Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Friday, May 08, 2026 03:57 AM
Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating ...
ARTV historical stock data
date open high low close volume
08/05/26 12.05 12.6799 10.20 10.89 5,293,847
07/05/26 12.34 12.58 12.00 12.52 151,793
06/05/26 11.31 13.00 11.00 12.39 308,378
05/05/26 11.16 11.37 10.5286 10.60 152,902
04/05/26 10.82 11.60 10.60 11.29 111,555
01/05/26 10.23 11.13 9.80 10.80 194,068
30/04/26 8.92 10.5199 8.75 10.24 271,189
29/04/26 9.04 9.3333 8.52 8.72 242,474
28/04/26 10.43 10.60 8.662 9.07 278,151
27/04/26 10.18 11.365 10.01 10.75 133,599
Quote Details
52wk Low:1.47
52wk High:14.53
Vol:5.29M
Avg Vol(3m):5.9M
1Y Chng:+452.79%
1M Chng:+117.37%
Add to Watch List
More Information
Index US Composite
Market Cap. 309.45M